Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin

Cancer Research
Aleksandra M Dudek-PerićPatrizia Agostinis

Abstract

Systemic chemotherapy generally has been considered immunosuppressive, but it has become evident that certain chemotherapeutic drugs elicit immunogenic danger signals in dying cancer cells that can incite protective antitumor immunity. In this study, we investigated whether locoregionally applied therapies, such as melphalan, used in limb perfusion for melanoma (Mel-ILP) produce related immunogenic effects. In human melanoma biopsies, Mel-ILP treatment upregulated IL1B, IL8, and IL6 associated with their release in patients' locoregional sera. Although induction of apoptosis in melanoma cells by melphalan in vitro did not elicit threshold levels of endoplasmic reticulum and reactive oxygen species stress associated with danger signals, such as induction of cell-surface calreticulin, prophylactic immunization and T-cell depletion experiments showed that melphalan administration in vivo could stimulate a CD8(+) T cell-dependent protective antitumor response. Interestingly, the vaccination effect was potentiated in combination with exogenous calreticulin, but not tumor necrosis factor, a cytokine often combined with Mel-ILP. Our results illustrate how melphalan triggers inflammatory cell death that can be leveraged by immunomodula...Continue Reading

References

Sep 1, 1980·The British Journal of Surgery·A S Bulman, C W Jamieson
Jan 25, 2002·Annual Review of Pharmacology and Toxicology·Elias J Fernandez, Elias Lolis
Oct 14, 2004·Annals of the Rheumatic Diseases·B Moser, K Willimann
Jan 20, 2005·Journal of the National Cancer Institute·Timothy Whelan, Mark Levine
Dec 21, 2005·The Journal of Experimental Medicine·Noelia CasaresGuido Kroemer
Feb 4, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Esther BuytaertPatrizia Agostinis
Sep 16, 2006·Nature Reviews. Immunology·Laurence ZitvogelGuido Kroemer
Dec 26, 2006·Nature Medicine·Michel ObeidGuido Kroemer
Jun 21, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sylvia AdamsNina Bhardwaj
Jan 24, 2009·The EMBO Journal·Theocharis PanaretakisGuido Kroemer
Mar 12, 2010·Apoptosis : an International Journal on Programmed Cell Death·Abhishek D GargPatrizia Agostinis
Jun 15, 2010·Biochemical and Biophysical Research Communications·Yeon Yi LeeKyong Soo Park
Nov 30, 2010·Surgical Oncology Clinics of North America·Ryan S TurleyDouglas S Tyler
May 24, 2011·Cancer Research·Jitka FucikovaRadek Spísek
Jun 15, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Larry Robert Peters, Malini Raghavan
Apr 11, 2012·Pigment Cell & Melanoma Research·Jasper WoutersJoost J van den Oord
Jun 30, 2012·Science Translational Medicine·Samuel R DenmeadeJohn T Isaacs
Nov 20, 2012·Annual Review of Immunology·Guido KroemerLaurence Zitvogel
Jan 19, 2013·Science·Lisa M CoussensA Karolina Palucka
Feb 9, 2013·Cytokine & Growth Factor Reviews·Aleksandra M DudekPatrizia Agostinis
May 4, 2013·The Lancet Oncology·Bodo E Lippitz
May 21, 2013·Cell Death and Differentiation·A D GargP Agostinis
Aug 1, 2013·BioFactors·Abhishek D GargPatrizia Agostinis
Nov 20, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ga Bin ParkDae Young Hur
Jan 1, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julia White, Eleftherios Mamounas
Jan 15, 2014·Journal of Surgical Oncology·Omgo E Nieweg, Bin B R Kroon
Feb 25, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Malgorzata WachowskaJakub Golab
Mar 26, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Gabriela B FerreiraChantal Mathieu

❮ Previous
Next ❯

Citations

Dec 19, 2015·Cancer Cell·Lorenzo GalluzziGuido Kroemer
Sep 16, 2015·Current Hematologic Malignancy Reports·Xavier Cahu, Stefan N Constantinescu
Dec 5, 2015·Frontiers in Immunology·Abhishek D GargPatrizia Agostinis
Apr 12, 2016·Frontiers in Immunology·Abhishek D Garg, Patrizia Agostinis
Mar 10, 2016·Expert Opinion on Therapeutic Targets·Paul EggletonMarek Michalak
Feb 13, 2016·Biological Chemistry·Alexander R van VlietPatrizia Agostinis
Jun 27, 2017·Cytokine·Anne ShowalterAnnette R Khaled
Dec 7, 2017·Frontiers in Immunology·Kristian M Hargadon
Dec 7, 2017·Oncoimmunology·Abhishek D GargLorenzo Galluzzi
Nov 22, 2018·Cancer Science·Ashanti Concepción Uscanga-PalomequeCristina Rodríguez-Padilla
Oct 28, 2018·Journal of Cancer Research and Clinical Oncology·Miroslawa CichorekKrystyna Dzierzbicka
Nov 7, 2019·Expert Review of Clinical Pharmacology·Rebecca L Read, John F Thompson
Mar 27, 2020·Journal for Immunotherapy of Cancer·Lorenzo GalluzziFrancesco M Marincola
May 1, 2018·Oncotarget·Erminia RomanoPatrizia Agostinis
Aug 6, 2020·Cells·Jenny SprootenAbhishek D Garg
Feb 22, 2018·Physiological Reviews·Maysa SarhanAndreas Linkermann
Aug 17, 2019·Frontiers in Cell and Developmental Biology·Ken Maes, Karine Breckpot
Aug 12, 2020·Journal of Hematology & Oncology·Rong TangSi Shi
Aug 8, 2020·Nature Reviews. Clinical Oncology·Lorenzo GalluzziGuido Kroemer
Oct 14, 2017·Immunological Reviews·Abhishek D Garg, Patrizia Agostinis
Feb 1, 2020·Oncoimmunology·Isaure VanmeerbeekAbhishek D Garg
Nov 30, 2016·Frontiers in Oncology·Seyma DemirsoyPatrizia Agostinis
Aug 2, 2017·Oxidative Medicine and Cellular Longevity·Sander BekeschusRajesh Kumar Gandhirajan
Aug 17, 2016·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·W G LandA Linkermann
Dec 19, 2018·Frontiers in Oncology·Junko JohanssonAnna Martner
May 2, 2019·Frontiers in Cell and Developmental Biology·Alfonso Serrano-Del ValleIsabel Marzo
Jan 18, 2018·Cancer Immunology Research·Charlotte E AriyanJames P Allison
Dec 3, 2015·Cancer Research·Anna MartnerRoger Olofsson Bagge
Dec 3, 2015·Cancer Research·Abhishek D GargPatrizia Agostinis
Jan 17, 2021·Photodiagnosis and Photodynamic Therapy·Ivan S Mfouo-TyngaCristina Kurachi
Mar 7, 2021·Journal of Clinical Medicine·Hiromi KataokaShigenobu Yano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis